603229 Zhejiang Ausun Pharmaceutical
- 10.05
- -0.01-0.10%
Zhejiang Ausun Pharmaceutical News
Aoxiang Pharmaceutical's 2023 Profit Distribution and Capital Provident Fund Share Capital Transfer Plan Announcement
Aoxiang Pharmaceutical\'s announcement on the listing and circulation of non-public restricted shares
Aoxiang Pharmaceutical\'s 2022 Annual Equity Distribution Implementation Notice
Aoxiang Pharmaceutical\'s announcement on the results of directors\' share holdings reduction
Announcement on Aoxiang Pharmaceutical's 2022 profit distribution and capital transfer plan from the Capital Provident Fund
Aoxiang Pharmaceutical's Reminder Announcement on Passive Dilution of Shares and Changes in Equity of the Company's Controlling Shareholders
Aoxiang Pharmaceutical's announcement on the results of the non-public offering of A-shares and changes in share capital
Aoxiang Pharmaceutical's announcement on the progress of directors' shareholding reduction
Report on the issuance of non-public shares of Aoxiang Pharmaceutical
An indicative announcement by Aoxiang Pharmaceutical on the issuance of non-public A-share shares
Report of Guojin Securities Co., Ltd. on Aoxiang Pharmaceutical's non-public stock issuance process and the compliance of subscribers
Legal opinion of Beijing Hairun Tianrui Law Firm on Aoxiang Pharmaceutical's non-public stock issuance process and subscription target compliance
Aoxiang Pharmaceutical's announcement on the results of the reduction of shares held by controlling shareholders, directors, executives and shareholding platforms
Aoxiang Pharmaceutical's indicative announcement on changes in the interests of the company's controlling shareholders
Aoxiang Pharmaceutical's indicative announcement on changes in the interests of the company's controlling shareholders
Aoxiang Pharmaceutical's Simplified Equity Change Report - Zheng Zhiguo
Aoxiang Pharmaceutical's announcement on the progress of the controlling shareholder's share holdings
Aoxiang Pharmaceutical: Aoxiang Pharmaceutical's announcement on the early termination of the holdings reduction plan for controlling shareholders, directors, executives and shareholding platforms and subsequent holdings reduction plans
Aoxiang Pharmaceutical: Aoxiang Pharmaceutical's announcement that its application for a non-public offering of shares has been approved and approved by the China Securities Regulatory Commission
Aoxiang Pharmaceutical's announcement that the application for the non-public offering of shares was approved and approved by the China Securities Regulatory Commission
Analysis
Price Target
No Data
